idarubicin has been researched along with Lymphoma, B-Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleksyk, OM; Kryachok, IA | 1 |
| Alptekin, M; Erkutlu, I; Kilciksiz, S; Okan, V; Pehlivan, M; Sari, I; Yilmaz, M | 1 |
| Cotter, F; Rackstraw, C; Smith, PJ | 1 |
| Douglas, R; Michael, B; Nabil, S; Thomas, F | 1 |
4 other study(ies) available for idarubicin and Lymphoma, B-Cell
| Article | Year |
|---|---|
[IMMUNOHISTOCHEMICAL FACTORS OF SMALL-CELL LYMPHOMAS AND CHOICE OF TREATMENT WTTH LEVEL INCLUSION].
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Cyclophosphamide; Doxorubicin; Female; Gamma Rays; Gene Expression; Humans; Idarubicin; Immunohistochemistry; Ki-67 Antigen; Lymph Nodes; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Middle Aged; Prednisolone; Prednisone; Protein Kinase C beta; Proto-Oncogene Proteins c-bcl-2; Survival Analysis; Tumor Suppressor Protein p53; Ukraine; Vincristine | 2014 |
Modified IDARAM chemotherapy regimen for primary central nervous system lymphoma: experience of three cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cranial Irradiation; Cytarabine; Dexamethasone; Humans; Idarubicin; Immunohistochemistry; Lymphoma, B-Cell; Magnetic Resonance Imaging; Male; Middle Aged | 2008 |
DNA fragmentation as a consequence of cell cycle traverse in doxorubicin- and idarubicin-treated human lymphoma cells.
Topics: Apoptosis; Cell Cycle; DNA Damage; DNA Topoisomerases, Type II; Doxorubicin; Flow Cytometry; Humans; Idarubicin; Lymphoma, B-Cell; Tumor Cells, Cultured | 1994 |
Topoisomerase II inhibitor induced leukemia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Homosexuality, Male; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Metastasis; Neoplasms, Second Primary; Topoisomerase II Inhibitors | 2001 |